Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Elutia Inc. has finalized the sale of its SimpliDerm human acellular dermal matrix business for up to $11 million, including an $8 million upfront payment. The transaction strengthens Elutia’s balance sheet with non-dilutive capital and enables the company to focus on developing and commercializing NXT-41x, an antibiotic-eluting biomatrix targeting…
Enphase Energy has opened U.S. pre-orders for the IQ Battery C80, its first all-in-one, commercial battery storage system offering 80 kWh capacity and up to 40 kVA power. This modular, AC-coupled system supports various commercial and industrial applications, integrates with Enphase's microinverters, and aims to simplify deployment while enhancing …
INNOVATE CORP.'s equity method investment, MediBeacon Inc., has been nominated for the esteemed 2026 Prix Galien USA Best Medical Technology award for its innovative MediBeacon® TGFR™ System, a first-of-its-kind transdermal kidney function assessment technology. This nomination highlights the breakthrough nature of the TGFR System, which enables po…
CareCloud, Inc. (Nasdaq: CCLD) has partnered with KabaFusion to co-develop LailaCare, a first-of-its-kind AI-powered integrated platform designed to streamline and modernize home infusion therapy workflows and specialty pharmacy services. The platform aims to unify referral intake, patient engagement, revenue cycle management, and operational effic…
Humacyte, a US-based biotech company, announced the first commercial implantations of Symvess, their FDA-approved bioengineered human blood vessel, performed by Dr. Jeromy Brink in Arizona. Symvess provides an off-the-shelf vascular graft option for emergency limb salvage surgeries, reducing the need for vein harvesting. This milestone marks a sign…
One Stop Systems announced a $1.3 million contract award from the U.S. Navy's Naval Surface Warfare Center for its Gen5 ruggedized 3U short-depth server designed for high-speed shipboard data recording. This new relationship broadens OSS's presence within the Department of Defense's research and technology organizations. Deliveries are expected to …
Saratoga Investment Corp. announced a registered public offering of unsecured notes expected to trade on the NYSE under the symbol "SAX". The company received a BBB investment grade rating from Egan-Jones Ratings Company. Proceeds from the offering will be used to redeem existing notes and repay indebtedness, supporting the company’s financial flex…
Jefferson Capital, Inc. announced a proposed private offering of $100 million senior notes due 2030 through its subsidiary Jefferson Capital Holdings, LLC. The proceeds are intended primarily to repay borrowings under its revolving credit facility and for general corporate use. The notes are offered to qualified institutional buyers and non-U.S. pe…
Nasdaq has proposed extending U.S. equities trading to almost 23 hours a day by adding an overnight session from 9 PM to 4 AM ET, with an 8 PM to 9 PM ET pause for processing and a targeted launch of December 6, 2026, subject to SEC approval. The exchange would limit overnight activity to limit orders, use static price bands, and require new connec…
Wolfe Research analysts say the monthslong confrontation between the U.S. and Iran has settled into a prolonged stalemate after a framework ceasefire lapsed. They argue that, given reports of covert oil flows from the Gulf, oil prices are likely to remain elevated but not catastrophic, and U.S. inflation and yields have so far shown resilience. Key…
Klarna's stock plunged 17.1% in pre-market trading after the company published its second-quarter 2026 results ahead of the open. Management's guidance pointed to a sequential revenue decline versus Q1 and a narrower adjusted operating profit range, while provisions tied to its longer-duration Fair Financing product continued to climb, intensifying…
AVITA Medical announced positive results from its PermeaDerm-I clinical study demonstrating that PermeaDerm, a biosynthetic wound matrix, provides comparable clinical outcomes to cadaveric allograft for temporary wound coverage, while delivering a 70% reduction in product cost and a 96% reduction in preparation time. The randomized controlled trial…
Morgan Stanley published NielsenIQ All Measured Outlets sales figures for the most recent four-week period, revealing a modest acceleration in overall pet category growth versus the prior 12-week trend and divergent company-level results across pet food and cat litter. The dataset, which now incorporates additional retail channels such as Costco, x…
Globalstar shares moved lower in pre-market trade following a downgrade from Craig-Hallum and fresh evidence of significant insider selling. The company also reported a Q2 2026 EPS loss that fell short of expectations, while operational progress on satellite replenishment continued with the deployment of eight replacement satellites under a major c…
H & M Hennes & Mauritz B shares climbed after Citi placed the stock on a positive catalyst watch and raised its price target, while the Persson family disclosed a multi-million share purchase. The gains appear driven by these company-specific developments rather than a broader market rally ahead of the retailer’s third-quarter results next month.
IBM has fallen roughly one-third from its 52-week high and is trading near $229. The core thesis here is tactical: use a disciplined entry to capture upside from IBM's software-led recovery and steady free cash flow, while protecting against continued mainframe weakness. Valuation is reasonable for a mature tech company (market cap ~$216B, EV ~$270…
Citi upgraded Bath & Body Works from Neutral to Buy ahead of the retailer's upcoming second-quarter report, forecasting an earnings-per-share beat and highlighting a depressed share price, recent product momentum and possible upside from lower energy costs and tariff refunds as drivers of a favorable risk/reward profile.
Meren Energy offers a double incentive: a high-coupon-style dividend (around 7% today) and a reasonable recovery upside as oil & gas fundamentals normalize. This trade targets an entry at $18.50 with a long-term horizon, a conservative stop under $15.25, and a $26.00 target driven by normalization of multiples and steady free-cash conversion.
Precision BioSciences (DTIL) looks actionable after signals of promising HBV editing data. The stock trades at $7.41 with a market cap of $204.5M and an enterprise value of $140.6M. We lay out a mid-term swing trade sized for event risk: entry $7.41, initial target $12.00, stop loss $5.50. Catalysts include forthcoming clinical readouts and broader…
Prenetics Global Limited (NASDAQ: PRE) reported a 288% year-over-year revenue growth in Q2 2026 driven by its wellness brand IM8, which grew 359% YoY. The company raised its full-year 2026 revenue guidance to $220-230 million and expects over $400 million revenue from IM8 in 2027. July marked the first positive consolidated adjusted free cash flow …
Helus Pharma announced the appointments of Regina Donohue as Chief People Officer and Dr. Suresh Durgam to its Scientific Advisory Board. Both bring substantial experience from Intra-Cellular Therapies in scaling operations and CNS drug development, respectively. These strategic hires are aimed at bolstering Helus Pharma's organizational growth and…
Tilray Brands' BrewDog division announced its 2026 Advent Calendar featuring 24 craft beers, including returning favorites and new seasonal releases at a price of £51.99. The calendar and an exclusive glass are available for pre-order starting September 7, 2026. The product aims to enhance festive enjoyment and customer engagement in the growing cr…
Berenberg upgraded Sixt SE to Buy from Hold following encouraging second-quarter results and growing European travel demand. The broker raised price targets for both ordinary and preference shares and increased revenue and earnings forecasts for 2026-2028, citing stronger assumptions for Europe and a clearer U.S. residual-value approach. Sixt share…
monday.com's recent workforce reduction is a tactical reset that should materially improve operating leverage, reduce future dilution pressure, and support higher free cash flow. With revenue growth still in the mid-20s, a sub-$90 entry offers a favorable risk-reward into improving margins and improving enterprise traction.
U.S. stock futures opened lower as renewed U.S.-Iran tensions pushed oil prices up, reviving concerns that energy-driven inflation could limit Federal Reserve easing. In premarket trading, a mix of analyst upgrades, corporate earnings and clinical trial developments produced sharp moves across select technology, biotech and small-cap names.
